Intervention group: This study examines the bioequivalence of Fexofenadine tablets produced by a domestic company with a foreign brand sample. We have only one intervention group and there is no contr

2 trials

Sponsors

Tasnim, Koushan Pharmed Pharmaceutical Company

Conditions

Bioequivalence study in healthy volunteers.

Phase 1

Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg, tablet manufactured by Tasnim Company

Active, not recruitingIRCT20130313012810N16

TasnimBioequivalence study in healthy volunteers.

Start: 2023-11-02Target: 24Updated: 2023-11-13

Fexofenadine tablet bioequivalence

Active, not recruitingIRCT20130313012810N63

Koushan Pharmed Pharmaceutical CompanyBioequivalence study in healthy volunteers.

Start: 2025-08-01Target: 24Updated: 2025-08-19